Luciano Burattini

1.9k total citations
55 papers, 1.3k citations indexed

About

Luciano Burattini is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Luciano Burattini has authored 55 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 20 papers in Cancer Research. Recurrent topics in Luciano Burattini's work include Renal cell carcinoma treatment (27 papers), Renal and related cancers (15 papers) and Cancer Genomics and Diagnostics (12 papers). Luciano Burattini is often cited by papers focused on Renal cell carcinoma treatment (27 papers), Renal and related cancers (15 papers) and Cancer Genomics and Diagnostics (12 papers). Luciano Burattini collaborates with scholars based in Italy, United States and Spain. Luciano Burattini's co-authors include Matteo Santoni, Stefano Cascinu, Rossana Berardi, Alessandro Conti, Giorgio Santoni, Rodolfo Montironi, Giovanni Muzzonigro, Consuelo Amantini, Massimo Nabissi and Daniele Santini and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

Luciano Burattini

54 papers receiving 1.3k citations

Peers

Luciano Burattini

PRM

ONCOL

SURGE

Toshinari Yamasaki Japan

Carmen Belli Italy

Jiuda Zhao China

Jeremy Cetnar United States

Shuqiang Yuan China

Jan Cosaert United States

Vanja Vaccaro Italy

Satoru Moriyama Japan

Yong Mee Cho South Korea

Yun Jung Choi South Korea

Toshinari Yamasaki Japan

Luciano Burattini

684 ×1.1

PRM

391 ×0.6

ONCOL

581 ×1.2

361 ×1.1

194 ×0.9

SURGE

Citations per year, relative to Luciano Burattini Luciano Burattini (= 1×) peers Toshinari Yamasaki

Countries citing papers authored by Luciano Burattini

Since Specialization

Citations

This map shows the geographic impact of Luciano Burattini's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luciano Burattini with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luciano Burattini more than expected).

Fields of papers citing papers by Luciano Burattini

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luciano Burattini. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luciano Burattini. The network helps show where Luciano Burattini may publish in the future.

Co-authorship network of co-authors of Luciano Burattini

This figure shows the co-authorship network connecting the top 25 collaborators of Luciano Burattini. A scholar is included among the top collaborators of Luciano Burattini based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luciano Burattini. Luciano Burattini is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Galosi, Andrea Benedetto, et al.. (2021). Level IV tumor thrombus in non-metastatic renal cell cancer? No, thanks. Level II is better. Lessons learned from a case report. Urology Case Reports. 37. 101660–101660. 2 indexed citations

Tassone, Laura, Mariangela Torniai, Chiara Pierantoni, et al.. (2021). Seminoma Retroperitoneal Relapse 23 Years After Surgery. Oncology and Therapy. 9(1). 239–245. 2 indexed citations

Montironi, Rodolfo, Matteo Santoni, Roberta Mazzucchelli, et al.. (2016). Prostate cancer: from Gleason scoring to prognostic grade grouping. Expert Review of Anticancer Therapy. 16(4). 433–440. 25 indexed citations

Santoni, Matteo, Alessandro Conti, Francesco Piva, et al.. (2015). Role of STAT3 pathway in genitourinary tumors. PMC. 1 indexed citations

Conti, Alessandro, Matteo Santoni, Luciano Burattini, et al.. (2015). Small renal masses in the era of personalized medicine: Tumor heterogeneity, growth kinetics, and risk of metastasis. Urologic Oncology Seminars and Original Investigations. 33(7). 303–309. 13 indexed citations

Conti, Alessandro, Matteo Santoni, Luciano Burattini, et al.. (2015). Update on histopathological evaluation of lymphadenectomy specimens from prostate cancer patients. World Journal of Urology. 35(4). 517–526. 14 indexed citations

Giorgi, Ugo De, Karim Rihawi, Michele Aieta, et al.. (2014). Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer. Journal of Geriatric Oncology. 5(2). 156–163. 22 indexed citations

Santoni, Matteo, Alessandro Conti, Luciano Burattini, et al.. (2014). Neuroendocrine differentiation in prostate cancer: Novel morphological insights and future therapeutic perspectives. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1846(2). 630–637. 49 indexed citations

Santoni, Matteo, Francesco Pantano, Consuelo Amantini, et al.. (2014). Emerging strategies to overcome the resistance to current mTOR inhibitors in renal cell carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1845(2). 221–231. 49 indexed citations

10.

Santoni, Matteo, Alessandro Conti, Luciano Burattini, et al.. (2014). Alternative dosing schedules for sunitinib as a treatment of patients with metastatic renal cell carcinoma. Critical Reviews in Oncology/Hematology. 92(3). 208–217. 25 indexed citations

11.

Santoni, Matteo, Simon J. Crabb, Alessandro Conti, et al.. (2014). Conditional Survival of Patients Treated With First-Line Chemotherapy for Metastatic Urothelial Cancer. Clinical Genitourinary Cancer. 13(3). 244–249. 7 indexed citations

12.

Santoni, Matteo, Ugo De Giorgi, Roberto Iacovelli, et al.. (2013). Pre-treatment neutrophil-to-lymphocyte ratio may be associated with the outcome in patients treated with everolimus for metastatic renal cell carcinoma. British Journal of Cancer. 109(7). 1755–1759. 74 indexed citations

13.

Santoni, Matteo, Mimma Rizzo, Luciano Burattini, et al.. (2013). Novel Agents, Combinations and Sequences for the Treatment of Advanced Renal Cell Carcinoma: When is the Revolution Coming?. Current Cancer Drug Targets. 13(3). 313–325. 8 indexed citations

14.

Santoni, Matteo, Silvia Scoccianti, Ivan Lolli, et al.. (2013). Efficacy and safety of second-line fotemustine in elderly patients with recurrent glioblastoma. Journal of Neuro-Oncology. 113(3). 397–401. 14 indexed citations

15.

Santoni, Matteo, Consuelo Amantini, Maria Beatrice Morelli, et al.. (2013). Pazopanib and sunitinib trigger autophagic and non-autophagic death of bladder tumour cells. British Journal of Cancer. 109(4). 1040–1050. 65 indexed citations

16.

Giorgi, Ugo De, Emanuela Scarpi, Cosimo Sacco, et al.. (2013). Standard vs Adapted Sunitinib Regimen in Elderly Patients With Metastatic Renal Cell Cancer: Results From a Large Retrospective Analysis. Clinical Genitourinary Cancer. 12(3). 182–189. 19 indexed citations

17.

Santoni, Matteo, Daniele Santini, Francesco Massari, et al.. (2013). Heterogeneous drug target expression as possible basis for different clinical and radiological response to the treatment of primary and metastatic renal cell carcinoma: suggestions from bench to bedside. Cancer and Metastasis Reviews. 33(1). 321–331. 19 indexed citations

18.

Santoni, Matteo, Mimma Rizzo, Luciano Burattini, et al.. (2012). Present and Future of Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: Analysis of Hematologic Toxicity. Recent Patents on Anti-Infective Drug Discovery. 7(2). 104–110. 18 indexed citations

19.

Massacesi, Cristian, Annalisa La Cesa, F. Marcucci, et al.. (2006). Capecitabine and Mitomycin C Is an Effective Combination for Anthracycline- and Taxane-Resistant Metastatic Breast Cancer. Oncology. 70(4). 294–300. 17 indexed citations

20.

Massacesi, Cristian, Luciano Burattini, F. Marcucci, & M. Bonsignori. (2005). Short Communication: The Efficacy of Fixed Dose Rate Infusion of Gemcitabine Combined with IFN-α2a in Patients with Advanced Refractory Renal Cell Carcinoma. Journal of Interferon & Cytokine Research. 25(3). 165–168. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact